Clinical immunotoxicity of therapeutic proteins

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

(2012) Sotirios Tsiodras et al.   MAYO CLINIC PROCEEDINGS

The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome

(2008) Houli Wang et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Malignancy and biologic therapy in rheumatoid arthritis

(2008) Johan Askling et al.   CURRENT OPINION IN RHEUMATOLOGY

Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products

(2008) Eugen Koren et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Monoclonal Antibody First Dose Cytokine Release Syndromes–Mechanisms and Prediction

(2008) Mark Wing   Journal of Immunotoxicology

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

(2008) Christine H. Chung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Managing Premedications and the Risk for Reactions to Infusional Monoclonal Antibody Therapy

(2008) C. H. Chung   ONCOLOGIST

TNFα blockade in human diseases: An overview of efficacy and safety

(2007) Jan Lin et al.   CLINICAL IMMUNOLOGY

Protein therapeutics: a summary and pharmacological classification

(2007) Benjamin Leader et al.   NATURE REVIEWS DRUG DISCOVERY

Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents

(2007) Michelle F. Costa et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM